Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDarktrace Regulatory News (DARK)

Share Price Information for Darktrace (DARK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 588.00
Bid: 586.60
Ask: 587.00
Change: 1.00 (0.17%)
Spread: 0.40 (0.068%)
Open: 587.00
High: 589.20
Low: 585.20
Prev. Close: 587.00
DARK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights and Rule 2.9 Disclosure

19 Aug 2022 12:23

RNS Number : 6487W
Darktrace PLC
19 August 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO, OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANTLAWS OR REGULATIONS OF THAT JURISDICTION

FOR IMMEDIATE RELEASE

 

19 August 2022

Darktrace plc

("Darktrace")

 

Total Voting Rights and Rule 2.9 Disclosure

Darktrace announces the issue and allotment of shares in connection with the vesting of awards previously granted under its Darktrace plc 2021 Award Incentive Plan to certain Darktrace employees, such awards being pre-existing obligations of Darktrace prior to commencement of the offer period under the City Code on Takeovers and Mergers (the "Code").

Darktrace has issued and allotted an aggregate of 8,859,944 new ordinary shares of £0.01 each in Darktrace (the "New Shares") to be delivered to the trustee of The Darktrace Employee Benefit Trust. An application has been made for the New Shares to be admitted to the Premium Listing Segment of the Official List of the Financial Conduct Authority and to trading on the Main Market of the London Stock Exchange.

The New Shares will rank pari passu in all respects with Darktrace's existing ordinary shares of £0.01 nominal value each, each of which carries the right to one vote. It is expected that admission will become effective on 24 August 2022.

In accordance with Rule 2.9 of the Code, Darktrace confirms that as at the date of this announcement, the total number of ordinary shares of £0.01 each in issue is 719,705,647. The ordinary shares are, (and in the case of the New Shares will be), admitted to trading on the main market of the London Stock Exchange under the ISIN code GB00BNYK8G86.

Darktrace holds 1,778,403 ordinary shares as treasury shares with no voting rights.

Therefore the total voting rights figure of 717,927,244 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Darktrace under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Contact:

Luk Janssens - Head of Investor Relations, Darktrace

luk.janssens@darktrace.com

 

Disclosure requirements of the Takeover Code (the "Code")

 

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

 

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s), save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

 

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

 

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

 

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRBBGDIBDBDGDC
Date   Source Headline
31st Oct 20235:08 pmRNSTotal Voting Rights
31st Oct 20237:00 amRNSTransaction in Own Shares
30th Oct 20237:00 amRNSTransaction in Own Shares
27th Oct 20237:00 amRNSTransaction in Own Shares
26th Oct 20237:00 amRNSDarktrace Unveils New Cloud Security Solution
26th Oct 20237:00 amRNSTransaction in Own Shares
24th Oct 20237:00 amRNSTransaction in Own Shares
23rd Oct 20237:00 amRNSTransaction in Own Shares
20th Oct 20237:00 amRNSTransaction in Own Shares
19th Oct 20231:45 pmRNSHolding(s) in Company
19th Oct 20237:00 amRNSTransaction in Own Shares
18th Oct 20237:00 amRNSTransaction in Own Shares
17th Oct 202310:01 amRNSTransaction in Own Shares
16th Oct 20231:02 pmRNSHolding(s) in Company
12th Oct 20237:00 amRNSQ1 FY 2024 Trading Update
22nd Sep 202310:57 amRNSHolding(s) in Company
18th Sep 20231:55 pmRNSHolding(s) in Company
15th Sep 20234:33 pmRNSHolding(s) in Company - Replacement
15th Sep 20231:13 pmRNSHolding(s) in Company
13th Sep 20232:25 pmRNSTransaction in Own Shares
8th Sep 20234:57 pmRNSDirector Declaration
6th Sep 20237:00 amRNSFinal Results
31st Aug 20234:44 pmRNSTotal Voting Rights
31st Aug 20237:00 amRNSTransaction in Own Shares
30th Aug 20237:00 amRNSTransaction in Own Shares
25th Aug 20237:00 amRNSTransaction in Own Shares
24th Aug 20237:00 amRNSTransaction in Own Shares
23rd Aug 20237:00 amRNSTransaction in Own Shares
22nd Aug 202311:52 amRNSHolding(s) in Company
22nd Aug 20237:00 amRNSTransaction in Own Shares
21st Aug 20237:00 amRNSTransaction in Own Shares
18th Aug 20237:00 amRNSTransaction in Own Shares
2nd Aug 202310:32 amRNSHolding(s) in Company
31st Jul 20234:41 pmRNSTotal Voting Rights
28th Jul 20237:00 amRNSResults of Secondary Placing in Darktrace
27th Jul 20236:31 pmRNSPlacing of Shares in Darktrace by Summit Partners
26th Jul 20237:00 amRNSLaunch of Darktrace HEAL™
24th Jul 20233:06 pmRNSDirector/PDMR Shareholding
24th Jul 20233:01 pmRNSTR-1: Notification of major holdings
19th Jul 20237:00 amRNSTransaction in Own Shares
18th Jul 20237:00 amRNSQ4 FY 2023 Trading Update
18th Jul 20237:00 amRNSConclusion of Ernst & Young LLP Review
18th Jul 20237:00 amRNSTransaction in Own Shares
17th Jul 20237:00 amRNSTransaction in Own Shares
14th Jul 20237:00 amRNSTransaction in Own Shares
13th Jul 20237:00 amRNSTransaction in Own Shares
12th Jul 20237:00 amRNSDirector/PDMR Shareholding
12th Jul 20237:00 amRNSTransaction in Own Shares
11th Jul 20237:00 amRNSTransaction in Own Shares
10th Jul 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.